Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

51.8K
Overview
51.8K
What are Viruses?00:50

What are Viruses?

128.3K
Overview
128.3K
Cancer Vaccines01:30

Cancer Vaccines

1.1K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.1K
Introduction to Virus01:28

Introduction to Virus

1.7K
Viruses are unique biological entities that blur the boundary between living and non-living systems. Although they lack cellular structure and metabolic processes, they can exhibit characteristics of life when infecting a host. Their defining feature is a nucleic acid core, composed of either DNA or RNA, encapsulated within a protein coat called a capsid. This simple structure allows them to invade host cells and use their machinery for replication efficiently.Viral Structure and...
1.7K
Viruses of Archaea01:29

Viruses of Archaea

520
Archaeal viruses play a crucial role in the ecosystems of extremophilic archaea, particularly those belonging to the phyla Euryarchaeota and Crenarchaeota. By shaping host evolution and facilitating gene transfer, these viruses influence microbial communities and contribute to genetic diversity in extreme environments. The archaea they infect thrive in acidic hot springs and hydrothermal vents characterized by high temperatures and low pH. Archaeal viruses exhibit remarkable structural...
520
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

943
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
943

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early innate immune signatures correlate with Ad26.COV2.S vaccine durability and protective efficacy.

bioRxiv : the preprint server for biology·2026
Same author

A proteome-wide atlas of humoral immunity to <i>Mycobacterium tuberculosis</i> across the spectrum of disease.

Frontiers in immunology·2026
Same author

Am80-lipid nanoparticles serve as an enteric mucosal adjuvant following parenteral immunization with inactivated polio vaccine.

Science advances·2026
Same author

Safety, pharmacokinetics, and neutralisation activity of PGDM1400LS, VRC07-523LS, and PGT121.414.LS infused intravenously or subcutaneously (HVTN 140/HPTN 101 part B): a phase 1, randomised trial.

The lancet. HIV·2026
Same author

Distinct phases of immune system programming during ART-suppressed immunodeficiency virus infection.

bioRxiv : the preprint server for biology·2026
Same author

Displayed and encoded antigens on adenovirus vectors optimize humoral and cellular immune responses in rhesus macaques.

Journal of virology·2026

Related Experiment Video

Updated: Feb 8, 2026

Rescue and Characterization of Recombinant Virus from a New World Zika Virus Infectious Clone
07:35

Rescue and Characterization of Recombinant Virus from a New World Zika Virus Infectious Clone

Published on: June 7, 2017

10.2K

Zika virus vaccines.

Peter Abbink1, Kathryn E Stephenson1,2, Dan H Barouch3,4

  • 1Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

Nature Reviews. Microbiology
|June 21, 2018
PubMed
Summary

Developing a Zika virus (ZIKV) vaccine is crucial due to severe congenital defects. Promising vaccine candidates show potential in early trials, but clinical development challenges persist.

More Related Videos

Rescue of Recombinant Zika Virus from a Bacterial Artificial Chromosome cDNA Clone
08:10

Rescue of Recombinant Zika Virus from a Bacterial Artificial Chromosome cDNA Clone

Published on: June 24, 2019

27.5K
Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons
09:11

Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons

Published on: August 23, 2016

21.4K

Related Experiment Videos

Last Updated: Feb 8, 2026

Rescue and Characterization of Recombinant Virus from a New World Zika Virus Infectious Clone
07:35

Rescue and Characterization of Recombinant Virus from a New World Zika Virus Infectious Clone

Published on: June 7, 2017

10.2K
Rescue of Recombinant Zika Virus from a Bacterial Artificial Chromosome cDNA Clone
08:10

Rescue of Recombinant Zika Virus from a Bacterial Artificial Chromosome cDNA Clone

Published on: June 24, 2019

27.5K
Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons
09:11

Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons

Published on: August 23, 2016

21.4K

Area of Science:

  • Virology
  • Vaccinology
  • Public Health

Background:

  • The Zika virus (ZIKV) epidemic in the Americas highlighted severe health risks, especially congenital Zika syndrome in newborns.
  • Congenital Zika syndrome includes microcephaly and developmental issues, underscoring the urgent need for effective vaccines.

Purpose of the Study:

  • To review the progress of Zika virus vaccine development.
  • To discuss findings from preclinical studies and early-stage human trials.

Main Methods:

  • Review of recent preclinical research on ZIKV vaccine candidates.
  • Analysis of data from Phase I clinical trials of ZIKV vaccines.

Main Results:

  • Several ZIKV vaccine candidates have demonstrated promising immunogenicity and safety in preclinical and early clinical studies.
  • Early human trials indicate potential but also highlight areas needing further investigation.

Conclusions:

  • Despite promising early results, significant hurdles remain in the clinical development and licensure of ZIKV vaccines.
  • Continued research and clinical evaluation are essential to overcome challenges and deliver a safe and effective ZIKV vaccine.